S&P 500   4,567.00 (-1.90%)
DOW   34,483.72 (-1.86%)
QQQ   393.82 (-1.47%)
AAPL   165.30 (+3.16%)
MSFT   330.59 (-1.79%)
FB   324.46 (-4.01%)
GOOGL   2,837.95 (-2.50%)
AMZN   3,507.07 (-1.53%)
TSLA   1,144.76 (+0.68%)
NVDA   326.76 (-2.10%)
BABA   127.53 (-3.10%)
NIO   39.13 (-3.29%)
CGC   10.71 (-3.16%)
AMD   158.37 (-2.19%)
GE   94.99 (-3.47%)
MU   84.00 (-2.48%)
T   22.83 (-4.44%)
F   19.19 (-2.44%)
DIS   144.90 (-1.97%)
ACB   6.42 (-0.31%)
AMC   33.94 (-7.87%)
PFE   53.73 (+2.54%)
BA   197.85 (-0.33%)
S&P 500   4,567.00 (-1.90%)
DOW   34,483.72 (-1.86%)
QQQ   393.82 (-1.47%)
AAPL   165.30 (+3.16%)
MSFT   330.59 (-1.79%)
FB   324.46 (-4.01%)
GOOGL   2,837.95 (-2.50%)
AMZN   3,507.07 (-1.53%)
TSLA   1,144.76 (+0.68%)
NVDA   326.76 (-2.10%)
BABA   127.53 (-3.10%)
NIO   39.13 (-3.29%)
CGC   10.71 (-3.16%)
AMD   158.37 (-2.19%)
GE   94.99 (-3.47%)
MU   84.00 (-2.48%)
T   22.83 (-4.44%)
F   19.19 (-2.44%)
DIS   144.90 (-1.97%)
ACB   6.42 (-0.31%)
AMC   33.94 (-7.87%)
PFE   53.73 (+2.54%)
BA   197.85 (-0.33%)
S&P 500   4,567.00 (-1.90%)
DOW   34,483.72 (-1.86%)
QQQ   393.82 (-1.47%)
AAPL   165.30 (+3.16%)
MSFT   330.59 (-1.79%)
FB   324.46 (-4.01%)
GOOGL   2,837.95 (-2.50%)
AMZN   3,507.07 (-1.53%)
TSLA   1,144.76 (+0.68%)
NVDA   326.76 (-2.10%)
BABA   127.53 (-3.10%)
NIO   39.13 (-3.29%)
CGC   10.71 (-3.16%)
AMD   158.37 (-2.19%)
GE   94.99 (-3.47%)
MU   84.00 (-2.48%)
T   22.83 (-4.44%)
F   19.19 (-2.44%)
DIS   144.90 (-1.97%)
ACB   6.42 (-0.31%)
AMC   33.94 (-7.87%)
PFE   53.73 (+2.54%)
BA   197.85 (-0.33%)
S&P 500   4,567.00 (-1.90%)
DOW   34,483.72 (-1.86%)
QQQ   393.82 (-1.47%)
AAPL   165.30 (+3.16%)
MSFT   330.59 (-1.79%)
FB   324.46 (-4.01%)
GOOGL   2,837.95 (-2.50%)
AMZN   3,507.07 (-1.53%)
TSLA   1,144.76 (+0.68%)
NVDA   326.76 (-2.10%)
BABA   127.53 (-3.10%)
NIO   39.13 (-3.29%)
CGC   10.71 (-3.16%)
AMD   158.37 (-2.19%)
GE   94.99 (-3.47%)
MU   84.00 (-2.48%)
T   22.83 (-4.44%)
F   19.19 (-2.44%)
DIS   144.90 (-1.97%)
ACB   6.42 (-0.31%)
AMC   33.94 (-7.87%)
PFE   53.73 (+2.54%)
BA   197.85 (-0.33%)
NASDAQ:ATHA

Athira Pharma News Headlines

$13.48
-0.10 (-0.74%)
(As of 11/30/2021 12:00 AM ET)
Add
Compare
Today's Range
$12.89
$13.71
50-Day Range
$9.17
$16.39
52-Week Range
$8.88
$34.79
Volume
637,205 shs
Average Volume
629,924 shs
Market Capitalization
$503.49 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
3.89

Media Mentions By Week



Athira Pharma Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ATHA
News Sentiment

-0.86

0.27

Average
Medical
News Sentiment

Media Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ATHA Articles
This Week

1

4

ATHA Articles
Average Week

Get Athira Pharma News Delivered to You Automatically

Sign up to receive the latest news and ratings for ATHA and its competitors with MarketBeat's FREE daily newsletter.

Athira Pharma (NASDAQ:ATHA) News Headlines Today

SourceHeadline
MarketBeat logoFY2021 EPS Estimates for Athira Pharma, Inc. (NASDAQ:ATHA) Raised by Jefferies Financial Group
americanbankingnews.com - November 15 at 2:30 AM
MarketBeat logoTraders Purchase High Volume of Call Options on Athira Pharma (NASDAQ:ATHA)
americanbankingnews.com - November 12 at 8:00 AM
MarketBeat logoAthira Pharma (NASDAQ:ATHA) Issues Quarterly Earnings Results
americanbankingnews.com - November 11 at 2:26 PM
finance.yahoo.com logoAthira Pharma Reports Third Quarter 2021 Financial Results and Business Update
finance.yahoo.com - November 10 at 5:35 PM
finance.yahoo.com logoAthira Pharma Presents Overview and Update from ACT-AD and LIFT-AD Trials of ATH-1017 in mild-to-moderate Alzheimer’s Disease at CTAD Conference
finance.yahoo.com - November 10 at 12:35 PM
finance.yahoo.com logoAthira Pharma to Host Educational Webinar on the Clinical Applications of ERP P300
finance.yahoo.com - October 29 at 10:15 AM
finance.yahoo.com logoFormer Athira CEO addresses controversy and departure in letter to employees
finance.yahoo.com - October 25 at 8:10 AM
benzinga.com logo(ATHA) Alert: Did You Acquire Athira Before November 2020? Should Management be Held Accountable for Investors Losses? Contact Johnson Fistel
benzinga.com - October 23 at 2:50 PM
finance.yahoo.com logoAthira Pharma Stock Climbs on Alzheimer's Test; CEO Resignation
finance.yahoo.com - October 22 at 5:04 PM
finance.yahoo.com logoAthira CEO Resigns After Data Manipulation Firestorm, But Alzheimer's Stock Pops
finance.yahoo.com - October 22 at 5:04 PM
finance.yahoo.com logoAthira Pharma Announces Completion of Enrollment in Phase 2 ACT-AD Trial Evaluating ATH-1017 for Mild-to-Moderate Alzheimer’s Disease
finance.yahoo.com - October 22 at 12:03 PM
finance.yahoo.com logoWhy Shares of Athira Pharma Are Climbing Today
finance.yahoo.com - October 22 at 12:03 PM
finance.yahoo.com logoAthira Pharma Announces Leadership Changes; Mark Litton, Ph.D., M.B.A. Named President and Chief Executive Officer; Rachel Lenington, M.B.A. Named Chief Operating Officer
finance.yahoo.com - October 21 at 8:55 PM
finance.yahoo.com logoLeen Kawas officially out at Athira after investigation finds doctored research
finance.yahoo.com - October 21 at 8:55 PM
finance.yahoo.com logoAthira Pharma to Present Updates from Phase 2/3 Trials of ATH-1017 at the 2021 Clinical Trials on Alzheimer’s Disease (CTAD) Conference
finance.yahoo.com - September 29 at 7:15 PM
finance.yahoo.com logoAthira grant application used doctor's credentials without his knowledge
finance.yahoo.com - September 23 at 5:30 PM
nasdaq.com logoNotable Wednesday Option Activity: OPRX, ATHA, MPC
nasdaq.com - September 22 at 5:53 PM
finance.yahoo.com logoAthira Pharma, Inc. (ATHA) Dips More Than Broader Markets: What You Should Know
finance.yahoo.com - September 17 at 11:40 PM
finance.yahoo.com logoWe're Hopeful That Athira Pharma (NASDAQ:ATHA) Will Use Its Cash Wisely
finance.yahoo.com - September 14 at 7:14 AM
finance.yahoo.com logoATHA DEADLINE TODAY: Hagens Berman Encourages Athira Pharma (ATHA) Investors with Losses to Contact Firm's Attorneys Now, Lead Plaintiff Deadline Today
finance.yahoo.com - August 24 at 6:04 PM
finance.yahoo.com logoDEADLINE TODAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Athira Pharma, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
finance.yahoo.com - August 24 at 6:04 PM
finance.yahoo.com logoLast Day for Shareholders to Actively Participate in Athira Pharma, Inc. (ATHA) Class Action: Bronstein, Gewirtz & Grossman, LLC
finance.yahoo.com - August 24 at 6:04 PM
finance.yahoo.com logoFinal Hours for Shareholders to Actively Participate in Athira Pharma, Inc. (ATHA) Class Action: Bronstein, Gewirtz & Grossman, LLC
finance.yahoo.com - August 24 at 6:04 PM
finance.yahoo.com logoFINAL DEADLINE TOMORROW: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Athira Pharma, Inc. and Encourages Investors with Losses in Excess of $750,000 to Contact the Firm
finance.yahoo.com - August 24 at 2:39 AM
finance.yahoo.com logoATHIRA PHARMA 24 HOUR DEADLINE ALERT: FORMER LOUISIANA ATTORNEY GENERAL AND KAHN SWICK & FOTI, LLC REMIND INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Deadline in Class Action Lawsuits Against Athira Pharma, Inc. - ATHA
finance.yahoo.com - August 23 at 9:39 PM
finance.yahoo.com logoOne Day Remaining for Shareholders to Actively Participate in Athira Pharma, Inc. (ATHA) Class Action: Bronstein, Gewirtz & Grossman, LLC
finance.yahoo.com - August 23 at 4:38 PM
finance.yahoo.com logoLEAD PLAINTIFF DEADLINE TOMORROW: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Athira Pharma, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
finance.yahoo.com - August 23 at 4:38 PM
finance.yahoo.com logoATHA DEADLINE TOMORROW: Hagens Berman Encourages Athira Pharma (ATHA) Investors with Losses to Contact Firm’s Attorneys Now, August 24th Deadline in Securities Class Action
finance.yahoo.com - August 23 at 4:38 PM
finance.yahoo.com logoKessler Topaz Meltzer & Checker, LLP: Final Deadline Reminder for Athira Pharma, Inc. Investors – ATHA
finance.yahoo.com - August 23 at 4:38 PM
finance.yahoo.com logoFINAL DEADLINE TUESDAY: ROSEN, A LEADING LAW FIRM, Encourages Athira Pharma, Inc. Investors to Secure Counsel Before Important August 24 Deadline in Securities Class Action - ATHA
finance.yahoo.com - August 23 at 8:41 AM
finance.yahoo.com logoAthira Pharma to Present on ERP P300 as a Direct, Functional, Non-Invasive Biomarker at the Annual Biomarkers for Alzheimer’s Disease Summit
finance.yahoo.com - August 23 at 8:41 AM
finance.yahoo.com logoThe Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Athira Pharma, Inc. (ATHA)
finance.yahoo.com - August 23 at 3:41 AM
finance.yahoo.com logoATHIRA PHARMA 48 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors with Losses in Excess of $100,000 of Deadline in Class Action Lawsuits Against Athira Pharma, Inc. - ATHA
finance.yahoo.com - August 22 at 10:40 PM
finance.yahoo.com logoATHIRA DEADLINE ALERT: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Athira To Contact Him Directly To Discuss Their Options
finance.yahoo.com - August 22 at 5:39 PM
benzinga.com logoATHIRA PHARMA 96 HOUR DEADLINE ALERT: Former...
benzinga.com - August 21 at 4:56 PM
finance.yahoo.com logoATHA 3-DAY DEADLINE ALERT: Hagens Berman Encourages Athira Pharma (ATHA) Investors with Losses to Contact Firm’s Attorneys Before August 24th Deadline in Securities Class Action
finance.yahoo.com - August 21 at 4:56 PM
finance.yahoo.com logoSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Athira Pharma, Inc. - ATHA
finance.yahoo.com - August 21 at 4:56 PM
finance.yahoo.com logoATHIRA PHARMA 96 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors With Losses in Excess of $100,000 of Deadline in Class Action Lawsuits Against Athira Pharma, Inc. - ATHA
finance.yahoo.com - August 21 at 3:23 AM
finance.yahoo.com logo4-Day Deadline Alert: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Athira Pharma, Inc. and Encourages Investors with Losses in Excess of $250,000 to Contact the Firm
finance.yahoo.com - August 20 at 5:22 PM
finance.yahoo.com logoATHA FINAL DEADLINE: ROSEN, RESPECTED INVESTOR COUNSEL, Encourages Athira Pharma, Inc. Investors to Secure Counsel Before Important Tuesday Deadline in Securities Class Action – ATHA
finance.yahoo.com - August 20 at 5:22 PM
finance.yahoo.com logoLAWSUITS FILED AGAINST JRVR, ATHA and BLCT - JAKUBOWITZ LAW PURSUES SHAREHOLDERS CLAIMS
finance.yahoo.com - August 20 at 8:05 AM
finance.yahoo.com logoDEADLINE ALERT: Kessler Topaz Meltzer & Check, LLP Announces Deadline in Athira Pharma, Inc. Securities Fraud Class Action Lawsuit
finance.yahoo.com - August 19 at 10:04 PM
finance.yahoo.com logoFINAL DEADLINE NOTICE: ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Athira Pharma, Inc. Investors With Losses Exceeding $100K to Secure Counsel Before Important August 24 Deadline in Securities Class Action - ATHA
finance.yahoo.com - August 19 at 5:04 PM
finance.yahoo.com logoTUESDAY DEADLINE: Investors with Substantial Losses Have Opportunity to Lead the Athira Pharma, Inc. Class Action Lawsuit – ATHA
finance.yahoo.com - August 19 at 3:06 AM
finance.yahoo.com logoDeadline in 6 Days: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Class Action Lawsuit Against Athira Pharma, Inc. (ATHA)
finance.yahoo.com - August 18 at 10:06 PM
finance.yahoo.com logoTUESDAY DEADLINE ALERT: The Schall Law Firm Announces it is Investigating Claims Against Athira Pharma, Inc. and Encourages Investors with Losses to Contact the Firm
finance.yahoo.com - August 18 at 5:05 PM
finance.yahoo.com logoThe Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of ATHA, BZ and DIDI
finance.yahoo.com - August 18 at 5:05 PM
finance.yahoo.com logoDeadline in 6 Days: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Class Action Lawsuit Against Athira Pharma, Inc. (ATHA)
finance.yahoo.com - August 18 at 5:05 PM
finance.yahoo.com logoATHA 6-DAY DEADLINE ALERT: Hagens Berman Encourages Athira Pharma (ATHA) Investors with Losses to Contact Firm's Attorneys Now, Securities Class Action Pending
finance.yahoo.com - August 18 at 5:05 PM
nasdaq.com logoAthira Pharma Inc Shares Fall 0.5% Below Previous 52-Week Low - Market Mover
nasdaq.com - August 18 at 3:09 AM
Get Athira Pharma News Delivered to You Automatically

Sign up to receive the latest news and ratings for ATHA and its competitors with MarketBeat's FREE daily newsletter.

This page was last updated on 11/30/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.